Long-term follow-up of non-HLA and anti-HLA antibodies: Incidence and importance in renal transplantation

Transplantation Proceedings

Volumn 45, Issue 4, 2013, Pages 1462-1465

  Banasik, M ^a   Boratynska M ^a   Koscielska Kasprzak K ^a   Mazanowska, O ^a   Bartoszek, D ^a   Zabinska M ^a   Myszka, M ^a   Nowakowska, B ^b   Halon A ^a   Szyber, P ^a   Patrzalek D ^a   Klinger, M ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II ANTIBODY; ENDOTHELIAL CELL ANTIBODY; ENDOTHELIN RECEPTOR ANTAGONIST; HLA ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; CLINICAL ARTICLE; CLINICAL EVALUATION; CONFERENCE PAPER; FEMALE; FOLLOW UP; HLA MATCHING; HUMAN; HUMAN TISSUE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL;

ADULT; AUTOANTIBODIES; FEMALE; FOLLOW-UP STUDIES; HLA ANTIGENS; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 84878561150     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.11.025     Document Type: Conference Paper

References (26)

1. T.K. Sigdel, L. Li, T.Q. Tran Non-HLA antibodies to immunogenic epitopes predict the evolution of chronic renal allograft injury J Am Soc Nephrol 23 2012 750 763
2. B.J. Nankivell, S.I. Alexander Rejection of the kidney allograft N Engl J Med 363 2010 1451 1462
3. M. Banasik, M. Klinger Chronic allograft nephropathy - immunologic and nonimmunologic factors Ann Transplant 11 2006 7 10
4. B.J. Nankivell, R.J. Borrows, C.L. Fung The natural history of chronic allograft nephropathy N Engl J Med 349 2003 2326 2333
5. Q. Mao, P.I. Terasaki, J. Cai Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study Am J transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 7 2007 864 871
6. R.B. Colvin Antibody-mediated renal allograft rejection: diagnosis and pathogenesis J Am Soc Nephrol 18 2007 1046 1056
7. D. Dragun, D.N. Muller, J.H. Brasen Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection N Engl J Med 352 2005 558 569
8. D. Dragun, B. Hegner Non-HLA antibodies post-transplantation: clinical relevance and treatment in solid organ transplantation Contrib Nephrol 162 2009 129 139
9. M. Naesens, P. Khatri, L. Li Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes Kidney Int 80 2011 1364 1376
10. P.I. Terasaki A personal perspective: 100-year history of the humoral theory of transplantation Transplantation 93 2012 751 756
11. P.I. Terasaki, J. Cai Humoral theory of transplantation: further evidence Curr Opin Immunol 17 2005 541 554
12. J. Cai, P.I. Terasaki Humoral theory of transplantation: mechanism, prevention, and treatment Human Immunol 66 2005 334 342
13. P.I. Terasaki Humoral theory of transplantation Am J Transplant 3 2003 665 673
14. M. Banasik, M. Boratynska, B. Nowakowska Variability in donor-specific alloantibody production after transplantation Transplant Proc 39 2007 2715 2717
15. M. Banasik, M. Boratynska, B. Nowakowska C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients Transplant Proc 39 2007 2718 2720
16. M. Boratynska, M. Banasik, A. Halon Blood group Lewis alloantibodies cause antibody-mediated rejection in renal transplant recipients Transplant Proc 39 2007 2711 2714
17. B.L. Ferry, K.I. Welsh, M.J. Dunn Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients: association with chronic rejection Transplant Immunol 5 1997 17 24
18. B. Sis, G.S. Jhangri, S. Bunnag Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining Am J Transplant 9 2009 2312 2323
19. D. Glotz, N. Lucchiari, B. Pegaz-Fiornet Endothelial cells as targets of allograft rejection Transplantation 82 2006 S19 S21
20. Q. Sun, Z. Cheng, D. Cheng De novo development of circulating anti-endothelial cell antibodies rather than pre-existing antibodies is associated with post-transplant allograft rejection Kidney Int 79 2011 655 662
21. D. Dragun, J.H. Brasen, C. Schonemann Patients with steroid refractory acute vascular rejection develop agonistic antibodies targeting angiotensin II type 1 receptor Transplant Proc 35 2003 2104 2105
22. M. Yanagisawa, H. Kurihara, S. Kimura A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 332 1988 411 415
23. A. Inoue, M. Yanagisawa, S. Kimura The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes Proc Natl Acad Sci U S A 86 1989 2863 2867
24. M.D. Stegall, P.G. Dean, J. Gloor Mechanisms of alloantibody production in sensitized renal allograft recipients Am J Transplant 9 2009 998 1005
25. M.R. Clatworthy, M. Espeli, N. Torpey The generation and maintenance of serum alloantibody Curr Opin Immunol 22 2010 669 681
26. A.M. Jackson, M.B. Kuperman, R.A. Montgomery Multiple hyperacute rejections in the absence of detectable complement activation in a patient with endothelial cell reactive antibody Am J Transplant 12 2012 1643 1649